Table 2 |
|||
|
Comparison of the clinical characteristics of the children with shock and the other critically ill patients who received postpyloric nutrition |
|||
| Shock |
Other patients |
p |
|
|
|
|||
| Number of patients |
65 |
461 |
|
| Age (months) (median, range) |
12 (0.7–264) |
5 (0.1–228) |
.020 |
| Weight (kg) (median, range) |
8.8 (2.5–70) |
5.3 (2.1–70) |
.0001 |
| Sex (male/female) |
44/21 (2.1/1) |
248/213 (1.1/1) |
.045 |
| Cardiac surgery |
44 (67.7%) |
330 (71.6%) |
.559 |
| Dopamine (median, range) |
62 (95.4%) 10 (3–50) |
307 (66.6%) 5 (0.5–20) |
.0001 .0001 |
| Adrenaline (median, range) |
49 (75.4%) 0.3 (0.02–5) |
71 (15.4%) 0.2 (0.04–0.3) |
.0001 .001 |
| Milrinone (median, range) |
45 (69.2%) 0.7 (0.4–0.8) |
206 (44.7%) 0.5 (0.5–1) |
.0001 .246 |
| Acute renal failure |
26 (40%) |
27 (5.9%) |
.0001 |
| Hepatic disturbances |
3 (4.8%) |
6 (1.3%) |
.081 |
| Nosocomial pneumonia |
9 (15.5%) |
38 (8.9%) |
.152 |
| Mortality |
18 (27.7%) |
32 (6.9%) |
.0001 |
| Midazolam (median, range) |
64 (98.5%) 7 (2–16) |
384 (83.3%) 4 (0.5–20) |
.0001 .0001 |
| Fentanyl (median, range) |
64 (98.5%) 6.5 (1–14) |
366 (79.4%) 4 (1–25) |
.0001 .0001 |
| Vecuronium (median, range) |
51 (78.5%) 0.1 (0.1–0.25) |
179 (38.8%) 0.1 (0.1–0.3) |
.0001 .660 |
|
|
|||
|
Maximum dose of drugs during nutrition. Units: mcg/kg/min (dopamine, adrenaline, milrinone, midazolam); mcg/kg/h (fentanyl, vecuronium) |
|||
|
López-Herce et al. Nutrition Journal 2008 7:6 doi:10.1186/1475-2891-7-6 |
|||
